// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Outcomes of Neonates with a 10-minute Apgar Score of Zero: A Systematic Review and Meta-Analysis

Keira C. Kilmartin - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Infantile bilateral striatal necrosis

N/A

Parental Expectations and Preferences for Participation in Decision-Making in the Management of Febrile Young Infants

Nawal Alathari - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Pediatric End of Life Workshop: A Safe and Novel Place for Fellows to Learn

Johannah M. Scheurer - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Placental changes in pregnancies with anti-Ro/La antibodies.

Nikola Wilk - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

N/A

Playing the CARD (Comfort, Ask, Relax, Distract) Internet Game to Cope with Needle Fear and Pain: Results from User Testing

Anna Taddio - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Prevalence of Mild Traumatic Brain Injury in Early Childhood

Deborah A. Levine - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Traumatic brain injury

N/A

Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network meta-analysis

Souvik Mitra - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Acetaminophen

Quality of Life in Children with Sickle Cell Disease: Agreement between Parent and Child

Miguel E. Mejia-Sang - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Sickle cell anemia

N/A

Reduction in Use of Inhaled Nitric Oxide in Preterm Neonates Following Policy Implementation: A Quality Improvement Project

Chacko J. Joseph - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

INO

Reliability of echocardiography indices for patent ductus arteriosus evaluation among extremely preterm neonates by neonatologist experts in a national network

Dany E. Weisz - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Patent ductus arteriosus

N/A

Respiratory Support, Establishment of Full Oral Feeds, and Length of Hospital Stay in Preterm Infants ≥33 Weeks Postmenstrual Age (PMA) - A Comprehensive Analysis

Anjeline Bukhari - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

School Readiness Among a Population-Based Cohort of Children Born Preterm in Canada

Deepak Louis - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Sex-Specific Association between Neonatal Deep Grey Nuclei Growth and Neurodevelopmental Outcomes at 4.5 Years in Very Preterm Children

Connor Mabbott - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

White matter injury

N/A

Sickle Cell Disease Children with Fever Managed with a single ED visit and telephone follow-up

Evelyne D.Trottier - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Sickle cell anemia

ceftriaxone

Sildenafil administration to treat neonatal encephalopathy (SANE-01) and repair brain injury secondary to birth asphyxia: A randomized, double-blind, placebo-controlled pilot phase Ib study

Pia Wintermark - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Hypoxic-ischemic encephalopathy

Sildenafil citrate

Simulation-based Just-in-time Training for Teaching Neonatal Endotracheal Intubation : A Randomized Controlled Trial.

Ewa Gizicki - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

succinylcholine

Single-room vs. Open-Bay NICU Design, Cerebral Maturation and Sleep-wake Cycling in Preterm Infants

Debashish Chowdhury - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Sepsis

N/A

STEPP IN (Safe Transitions & Euthermia in the Perioperative Period in Infants & Neonates) Next Steps: Quality Improvement Enhances Team Culture of Safety

Eugenia Pallotto - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Sulcal Pattern in Congenital Heart Disease is Associated with High-Brain Expressed and Chromatin-Modifying Gene Variants

Sarah U. Morton - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congenital heart disease

N/A

The Association Between BMI Trajectories and Bronchopulmonary Dysplasia Among Preterm Infants Born Less Than 30 Weeks Gestational Age

Laura Li Ching Ng - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Infant Respiratory Distress Syndrome

N/A

Copyright © 2026. QuantiNova All rights reserved